8-K
filed September 14, 2023, 7:59 PM ET
ticker OFIX
CIK 0000884624
leadership
confidence high
sentiment negative
materiality 0.85
Orthofix terminates CEO, CFO, CLO for misconduct; appoints interim replacements
Orthofix Medical Inc.
- Keith Valentine, John Bostjancic, Patrick Keran fired for cause after investigation found repeated inappropriate and offensive conduct.
- Catherine Burzik (Board Chair) named Interim CEO; Geoffrey Gillespie (VP Corp Controller) Interim CFO; Puja Leekha (Chief Ethics & Compliance) Interim CLO.
- Company states misconduct unrelated to strategy, results, or previously filed financial statements.
- Board will immediately search for permanent successors; created Executive Committee with broad authority.
- Morgan Stanley conference participation on Sep 13 canceled; investor day planned for Sep 20 postponed.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Geoffrey C. Gillespie was appointed as Interim Chief Financial Officer at Orthofix Medical Inc..
- Action
- appointed
- Role
- Interim Chief Financial Officer
Exact text from the filing
The Board also appointed Geoffrey C. Gillespie as Interim Chief Financial Officer and Puja Leekha as Interim Chief Legal Officer, each effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Keith Valentine was terminated as Chief Executive Officer at Orthofix Medical Inc..
- Action
- terminated
- Role
- Chief Executive Officer
Exact text from the filing
On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Catherine M. Burzik was appointed as Interim Chief Executive Officer at Orthofix Medical Inc..
- Action
- appointed
- Role
- Interim Chief Executive Officer
Exact text from the filing
Also on September 11, 2023, the Board appointed Catherine M. Burzik, the current Chair of the Board, as Interim Chief Executive Officer, effectively immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Bostjancic was terminated as Chief Financial Officer at Orthofix Medical Inc..
- Action
- terminated
- Role
- Chief Financial Officer
Exact text from the filing
On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Patrick Keran was terminated as Chief Legal Officer at Orthofix Medical Inc..
- Action
- terminated
- Role
- Chief Legal Officer
Exact text from the filing
On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Puja Leekha was appointed as Interim Chief Legal Officer at Orthofix Medical Inc..
- Action
- appointed
- Role
- Interim Chief Legal Officer
Exact text from the filing
The Board also appointed Geoffrey C. Gillespie as Interim Chief Financial Officer and Puja Leekha as Interim Chief Legal Officer, each effective immediately.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.